The CLL hunters: finally, BTK got arrested by Loic Ysebaert

Get full text

Assessment of Seasonality in Eosinophilic Dermatosis of Haematological Malignancy by Aurore Brun, Loic Ysebaert, Lucie Oberic, Laurence Lamant, Vincent Sibaud

Get full text

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy by Sarah Cadot, Loïc Ysebaert, Sébastien Lamy, Camille Laurent, Anne Quillet-Mary

Get full text

Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey by Gisèle Compaci, Cécile Conte, Lucie Oberic, Loïc Ysebaert, Guy Laurent, Fabien Despas

Get full text

Hemoglobin concentration; a pathway to frailty by Zara Steinmeyer, Cyrille Delpierre, Gaelle Soriano, Armand Steinmeyer, Loic Ysebaert, Laurent Balardy, Sandrine Sourdet

Get full text

Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions by Jennifer Series, Cédric Garcia, Marie Levade, Julien Viaud, Pierre Sié, Loïc Ysebaert, Bernard Payrastre

Get full text

Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia by Emmanuelle Bouvet, Cécile Borel, Lucie Obéric, Gisèle Compaci, Bruno Cazin, Anne-Sophie Michallet, Guy Laurent, Loic Ysebaert

Get full text

A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells. by Fabienne De Toni-Costes, Mathieu Despeaux, Jessica Bertrand, Ezzeddine Bourogaa, Loïc Ysebaert, Bernard Payrastre, Claire Racaud-Sultan

Get full text

PB1925: NAOS STUDY: FIRST INTERIM ANALYSIS OF ACALABRUTINIB USE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN A REAL-LIFE SETTING. by Anne Quinquenel, Marie Sarah Dilhuydy, Loïc Ysebaert, Stephane Lepretre, Christine Boileau, Gaëlle Cordonnier, Hassiba Ould Lahsen, Vincent Levy

Get full text

Health-related quality of life in patients with hematologic malignancies treated with chimeric antigen receptor T-cell therapy: review and current progress by Emmanuelle Tchernonog, Aline Moignet, Amélie Anota, Sophie Bernard, Guy Bouguet, Fanny Colin, Catherine Rioufol, Loïc Ysebaert, Emmanuel Gyan

Get full text

An agent-based model of monocyte differentiation into tumour-associated macrophages in chronic lymphocytic leukemia by Nina Verstraete, Malvina Marku, Marcin Domagala, Hélène Arduin, Julie Bordenave, Jean-Jacques Fournié, Loïc Ysebaert, Mary Poupot, Vera Pancaldi

Get full text

Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data by Félicien Le Louedec, Fanny Gallais, Fabienne Thomas, Mélanie White-Koning, Ben Allal, Caroline Protin, Loïc Ysebaert, Étienne Chatelut, Florent Puisset

Get full text

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia by Martin Gauthier, Françoise Durrieu, Elodie Martin, Michael Peres, François Vergez, Thomas Filleron, Lucie Obéric, Fontanet Bijou, Anne Quillet Mary, Loic Ysebaert

Get full text

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling. by Sarah Cadot, Chloe Audebert, Charlotte Dion, Soleakhena Ken, Loic Dupré, Laetitia Largeaud, Camille Laurent, Loic Ysebaert, Fabien Crauste, Anne Quillet-Mary

Get full text

Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia by Javier Rey-Barroso, Alice Munaretto, Nelly Rouquié, Aurélie Mougel, Malika Chassan, Sébastien Gadat, Océane Dewingle, Renaud Poincloux, Sarah Cadot, Loïc Ysebaert, Anne Quillet-Mary, Loïc Dupré

Get full text

P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERON... by Loïc Ysebaert, Xavier Troussard, Vincent Levy, Ronan Le Calloch, Romain Guieze, Kamel Laribi, Stephane Lepretre, Anne Sophie Michallet, Véronique Leblond, Pierre Feugier, Elhem Lahjibi, Julien Ramier, Alain Delmer

Get full text

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies by Suzanne Tavitian, Jean-Marie Peron, Françoise Huguet, Nassim Kamar, Florence Abravanel, Odile Beyne-Rauzy, Lucie Oberic, Stanislas Faguer, Laurent Alric, Murielle Roussel, Clément Gaudin, Loïc Ysebaert, Anne Huynh, Christian Recher

Get full text

P1687: LIFE AFTER CAR T-CELLS: DO PATIENTS RECOVER A NORMAL LIFE? by Alya Perthus, Fanny Colin, Emilie Charton, Amelie Anota, Sophie De Guibert, Loïc Ysebaert, Pierre Daufresne, Faustine Lhomme, Guillaume Manson, Adeline Bellec, Laetitia Le Bars, Thierry Lamy De La Chapelle, Roch Houot, Aline Moignet

Get full text

DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status by Srdana Grgurevic, Patricia Montilla-Perez, Alice Bradbury, Julia Gilhodes, Sophie Queille, Sandrine Pelofy, Aurélien Bancaud, Thomas Filleron, Loïc Ysebaert, Christian Récher, Guy Laurent, Jean-Jacques Fournié, Christophe Cazaux, Anne Quillet-Mary, Jean-Sébastien Hoffmann

Get full text

Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine by Jean-Jacques Fournié, Cathy Quelen, Camille Laurent, Patricia Pérez-Galán, Juan Garcia Valero, Carla Faria, Fabien Gava, Pauline Gravelle, Celia Dobaño-López, Nathalie Van Acker, Gael Jalowicki, Renaud Morin, Cédric Rossi, Jean-Michel Lagarde, Loïc Ysebaert, Christine Bezombes

Get full text